These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37699378)

  • 1. Commentary on "Early (<7 Days) Systemic Postnatal Corticosteroids for Prevention of Bronchopulmonary Dysplasia in Preterm Infants".
    Bamat NA; Soll RF
    Neonatology; 2023; 120(6):805-811. PubMed ID: 37699378
    [No Abstract]   [Full Text] [Related]  

  • 2. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia - Who might benefit?
    Doyle LW; Cheong JLY
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):290-295. PubMed ID: 28734731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal corticosteroids for preterm infants--do what we say, not what we do.
    Jobe AH
    N Engl J Med; 2004 Mar; 350(13):1349-51. PubMed ID: 15044647
    [No Abstract]   [Full Text] [Related]  

  • 4. Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.
    Jensen EA; Watterberg KL
    Neoreviews; 2023 Nov; 24(11):e691-e703. PubMed ID: 37907402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of inhaled corticosteroids in chronically ventilated preterm infants.
    Nelin LD; Logan JW
    Semin Fetal Neonatal Med; 2017 Oct; 22(5):296-301. PubMed ID: 28768578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Doyle LW
    Neonatology; 2021; 118(2):244-251. PubMed ID: 33975319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia.
    Doyle LW; Halliday HL; Ehrenkranz RA; Davis PG; Sinclair JC
    J Pediatr; 2014 Dec; 165(6):1258-60. PubMed ID: 25217197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby.
    Rostas SE; McPherson C
    Neonatal Netw; 2016; 35(4):234-9. PubMed ID: 27461202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
    Zhang ZQ; Zhong Y; Huang XM; Du LZ
    BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
    Committee on Fetus and Newborn
    Pediatrics; 2002 Feb; 109(2):330-8. PubMed ID: 11826218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Concepts of Corticosteroids Use for the Prevention of Bronchopulmonary Dysplasia.
    Perrone S; Orlando S; Petrolini C; Marinelli F; Moretti S; Corradi M; Giordano M; De Bernardo G
    Curr Pediatr Rev; 2023; 19(3):276-284. PubMed ID: 36043724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal corticosteroid response in neonates < 32 weeks and relation with placental pathology.
    Koenders VM; Appels A; van Straaten HLM; Dutman AC; Hemels MAC
    Eur J Pediatr; 2023 Jan; 182(1):265-274. PubMed ID: 36318297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.